Bengaluru, India

Srinivas Cheruku

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Srinivas Cheruku

Introduction

Srinivas Cheruku is a prominent inventor based in Bengaluru, India, known for his significant contributions to the field of pharmaceutical sciences. With a total of 16 patents to his name, he has made remarkable strides in developing compounds that target various medical conditions.

Latest Patents

Among his latest patents, Cheruku has disclosed substituted amide compounds that serve as farnesoid X receptor modulators. These compounds are designed to modulate the activity of the farnesoid X receptor (FXR), which plays a crucial role in various physiological processes. Additionally, he has developed substituted bicyclic compounds that also act as FXR modulators, providing potential therapeutic avenues for conditions such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders.

Career Highlights

Cheruku has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Syngene International Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug discovery.

Collaborations

Throughout his career, Cheruku has collaborated with talented individuals such as Susheel Jethanand Nara and Soodamani Thangavel. These partnerships have fostered innovation and have been instrumental in advancing his research initiatives.

Conclusion

Srinivas Cheruku's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations highlight his commitment to addressing critical health challenges through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…